Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico

References

• Holmes AH, Moore LSP, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187. doi:10.1016/S0140-6736(15)00473-026603922
   PubMed Web of Science ®Google Scholar
• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12(12):1–18. doi:10.1371/journal.pone.0189621
   Web of Science ®Google Scholar
• Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant Acinetobacter baumannii. Int J Infect Dis. 2015;38:32–35. doi:10.1016/j.ijid.2015.06.01426129972
   PubMed Web of Science ®Google Scholar
• Centres for Disease Control and Prevention UD of H and HS. Antibiotic Resistance: A Global Threat. World Health Organization; 2013.
   Google Scholar
• O’Neil J. Review on antibiotic resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Health Wealth Nations. 2014;(December):1–16.
   Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance; 2015. Available from: https://www.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1. Accessed October 20, 2021.
   Google Scholar
• Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.24598596
   PubMed Web of Science ®Google Scholar
• Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315. doi:10.1001/jamainternmed.2017.193828604925
   PubMed Web of Science ®Google Scholar
• Marchaim D, Chopra T, Bhargava A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817–830. doi:10.1086/66664222759550
   PubMed Web of Science ®Google Scholar
• Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(Suppl4):341–345. doi:10.1086/382690
   Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–1081. doi:10.1086/53345218419525
   PubMed Web of Science ®Google Scholar
• Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;(2):Art. No.: CD003543. doi:10.1002/14651858.CD003543.pub4
   Web of Science ®Google Scholar
• Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997–2007. Rev Panam Salud Publica/Pan Am J Public Health. 2010;27(3):219–225. doi:10.1590/S1020-49892010000300009
   PubMed Web of Science ®Google Scholar
• Huerta-Gutiérrez R, Braga L, Camacho-Ortiz A, et al. One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America. Int J Infect Dis. 2019;86:157–166. doi:10.1016/j.ijid.2019.06.01631229613
   PubMed Web of Science ®Google Scholar
• Aguilar-Rodea B, Cureño-Diaz M, Alvarez-Montero F, Valdes-Castro R, Valdez-Vázquez R, Figueroa-Moreno R. Epidemiology of healthcare-associated infections at a General Hospital in Mexico City: 2013–2014. Open Forum Infect Dis. 2015;2(suppl_1). doi:10.1093/ofid/ofv133.1269
   Google Scholar
• Garza-González E, Morfín-Otero R, Mendoza-Olazarán S, et al. A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period. PLoS One. 2019;14(3):1–13. doi:10.1371/journal.pone.0209865
   Web of Science ®Google Scholar
• Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, et al. Antimicrobial resistance and antibiotic consumption in Mexican hospitals. Salud Publica Mex. 2020;62(1):42–49.31869560
   PubMed Web of Science ®Google Scholar
• Álvarez de Iturbe I, Chirino-Barceló Y, López López A, Zamorano Jiménez CA, Nava Frías M. Uso de la profilaxis antimicrobiana en el Departamento de Cirugía en un hospital de tercer nivel de atención. An Med. 2013;58(4):247–252.
   Google Scholar
• Solís-Téllez H, Mondragón-Pinzón EE, Ramírez-Marino M, et al. Epidemiologic analysis: prophylaxis and multidrug-resistance in surgery. Rev Gastroenterol México. 2017;82(2):115–122. doi:10.1016/j.rgmxen.2016.12.002
   Google Scholar
• Palacios-Saucedo G Del C, de la Garza-camargo M, Briones-Lara E, et al. Evaluación del uso de antibióticos e impacto de una intervención dirigida a modificar la conducta prescriptiva en profilaxis quirúrgica en 6 hospitales del área metropolitana de Monterrey. Cir Cir. 2017;85(6):459–470. doi:10.1016/j.circir.2016.10.03328063606
   PubMed Web of Science ®Google Scholar
• Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–1504. doi:10.1086/64461719842976
   PubMed Web of Science ®Google Scholar
• Zarb P, Amadeo B, Muller A, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC point prevalence survey 2009. J Antimicrob Chemother. 2011;66(2):443–449. doi:10.1093/jac/dkq43021084362
   PubMed Web of Science ®Google Scholar
• Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619–e629. doi:10.1016/S2214-109X(18)30186-429681513
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO methodology for point prevalence survey on antibiotic use in hospitals, version 1.1; 2018. Available from: https://www.who.int/medicines/access/antimicrobial_resistance/WHO-EMP-IAU-2018_01/en/. Accessed October 20, 2021.
   Google Scholar
• Zumaya-Estrada FA, Alpuche-Aranda CM, Saturno-Hernandez PJ. The WHO methodology for point prevalence surveys on antibiotics use in hospitals should be improved: lessons from pilot studies in four Mexican hospitals. Int J Infect Dis. 2021;108:13–17. doi:10.1016/j.ijid.2021.04.07933932602
   PubMed Web of Science ®Google Scholar
• World Health Organization. International language for drug utilization research; 2020. Available from: https://www.whocc.no/. Accessed October 20, 2021.
   Google Scholar
• IBM. IBM SPSS statistics for windows; 2017.
   Google Scholar
• GraphPad. GraphPad QuickCalcs; 2021. Available from: https://www.graphpad.com/quickcalcs/confInterval1//. Accessed October 20, 2021.
   Google Scholar
• Magill SS, Edwards JR, Beldavs ZG, et al. Prevalence of antimicrobial use in us acute care hospitals, May–September 2011. JAMA. 2014;312(14):1438–1446. doi:10.1001/jama.2014.1292325291579
   PubMed Web of Science ®Google Scholar
• Soria-Orozco M, Padrón-Salas A, González-mercado J de J, et al. Prevalencia de uso de antimicrobianos entre pacientes hospitalizados en áreas no críticas en un hospital universitario de México. Salud Publica Mex. 2017;59(5):504–505. doi:10.21149/846529267640
   PubMed Web of Science ®Google Scholar
• Porto APM, Goossens H, Versporten A, Costa SF. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals. J Hosp Infect. 2020;104(2):165–171. doi:10.1016/j.jhin.2019.10.01631678430
   PubMed Web of Science ®Google Scholar
• World Health Organization. The 2019 WHO AWaRe classification of antibiotics for evaluation and monitoring of use; 2019. Available from: https://www.who.int/publications/i/item/WHOEMPIAU2019.11. Accessed October 20, 2021.
   Google Scholar
• Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Pharm. 2013;70(3):195–283. doi:10.2146/ajhp120568
   PubMedGoogle Scholar
• Lakbar I, De Waele JJ, Tabah A, Einav S, Martin-Loeches I, Leone M. Antimicrobial de-escalation in the ICU: from recommendations to level of evidence. Adv Ther. 2020;37(7):3083–3096. doi:10.1007/s12325-020-01390-232462606
   PubMed Web of Science ®Google Scholar
• Rawat D, Nair D. Extended-spectrum β-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263–274. doi:10.4103/0974-777X.6853120927289
   PubMedGoogle Scholar
• Garza-González E, Bocanegra-Ibarias P, Bobadilla-Del-Valle M, et al. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: results from the infivar network. PLoS One. 2021;16(3):e0248614. doi:10.1371/journal.pone.024861433730101
   PubMed Web of Science ®Google Scholar
• CDC. The core elements of hospital antibiotic stewardship programs: 2019; 2019. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Accessed October 20, 2021.
   Google Scholar
• Wagner B, Filice GA, Drekonja D, et al. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol. 2014;35(10):1209–1228. doi:10.1086/67805725203174
   PubMed Web of Science ®Google Scholar
• Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial. Antimicrob Agents Chemother. 2016;60(8):4840–4852. doi:10.1128/AAC.00825-1627246783
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:51–77. doi:10.1093/cid/ciw118
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A practical toolkit. 2019.
   Google Scholar
• Wilkinson A, Ebata A, Macgregor H. Interventions to reduce antibiotic prescribing in LMICs: a scoping review of evidence from human and animal health systems. Antibiotics. 2019;8(1). doi:10.3390/antibiotics8010002
   Web of Science ®Google Scholar
• Oliveira I, Rego C, Semedo G, et al. Systematic review on the impact of guidelines adherence on antibiotic prescription in respiratory infections. Antibiotics. 2020;9(9):1–19. doi:10.3390/antibiotics9090546
   Web of Science ®Google Scholar
• Segala FV, Murri R, Taddei E, et al. Antibiotic appropriateness and adherence to local guidelines in perioperative prophylaxis: results from an antimicrobial stewardship intervention. Antimicrob Resist Infect Control. 2020;9(1):1–6. doi:10.1186/s13756-020-00814-631908772
   PubMed Web of Science ®Google Scholar
• Vercheval C, Gillet M, Maes N, et al. Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. Eur J Clin Microbiol Infect Dis. 2016;35(9):1495–1500. doi:10.1007/s10096-016-2690-027255220
   PubMed Web of Science ®Google Scholar